Medication middlemen face bipartisan criticism as Congress eyes industry reforms
Executives from three of the largest pharmacy benefit managers (PBMs) pushed back against bipartisan criticism during a House Oversight Committee...
Read more
Executives from three of the largest pharmacy benefit managers (PBMs) pushed back against bipartisan criticism during a House Oversight Committee...
Read more
